Status:
COMPLETED
Acceptability of a COVID-19 Vaccine Among US Adults Over Two Time Periods
Lead Sponsor:
Columbia University
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Covid19
Vaccine Acceptability
Eligibility:
All Genders
18+ years
Brief Summary
The overall purpose of this study is to address the factors associated with an individual's personal willingness to get the vaccine and attitudes about potential public policy approaches to implementa...
Detailed Description
The overall objective is to address attitudes about potential public policy approaches to implementation of a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccine and the factors assoc...
Eligibility Criteria
Inclusion
- 18 years of age and older
- Able to read English and Spanish
- Panelists with Ipsos (KnowledgePanel)
Exclusion
- 17 years of age and younger
- Not able to read English or Spanish
- Not a member of Ipsos (KnowledgePanel)
Key Trial Info
Start Date :
April 7 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 18 2022
Estimated Enrollment :
1208 Patients enrolled
Trial Details
Trial ID
NCT04703790
Start Date
April 7 2021
End Date
February 18 2022
Last Update
March 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Irving Medical Center
New York, New York, United States, 10032